Panblok

recombinant H7 hemagglutinin vaccine (H7 rHA) · Protein Sciences Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Panblok, covering 2017-10-26 to 2017-10-26. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older [Phase 1, Phase 2]

See pricing